Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the field of otorhinolaryngology. With a rich history spanning from 1970 to the present, this journal serves as a crucial resource for medical professionals, researchers, and students interested in the latest developments and treatment modalities in ear, nose, and throat disorders. While the journal does not currently offer open access, it maintains a reputable standing in the academic community, reflected in its 2023 category quartile rankings, placing it in Q3 for Medicine (miscellaneous) and Q2 for Otorhinolaryngology. Furthermore, it ranks #53 out of 123 in the Medicine - Otorhinolaryngology category in Scopus, encompassing the 57th percentile. Researchers and practitioners turn to this journal for insightful articles that contribute to the advancement of clinical practice and enhance patient care.

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.

Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY is a premier peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the fields of allergy, asthma, and immunology. With its roots dating back to 1995 and with a focus on high-impact research, this journal has established itself as a leading platform for the dissemination of original research, reviews, and clinical studies within these critical areas. The journal boasts an impressive impact factor, supporting its Q2 ranking in both Immunology and Allergy, as well as in Pulmonary and Respiratory Medicine, indicating its significant contribution to the scientific community. Although it does not currently offer open access options, its comprehensive coverage and rigorous peer-review process ensure that published articles are of the highest quality, making it an invaluable resource for researchers, clinicians, and students alike. The Scopus rankings reflect its esteemed position in the academic landscape, providing professionals with access to cutting-edge developments and insights into the management and treatment of allergic and respiratory conditions.

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.